Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Elevation of Fatty Acid Levels and Cerebral Glucose Transport
NCT04328337Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Dec 2020
- Primary completion
- Jun 2026
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Intralipid 10% in obesity, sponsored by University of North Carolina at Chapel Hill. Started Dec 2020; status: completed.
02
Drugs
Intralipid 10%
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04328337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04328337.